Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

26.75 -2.92 (-9.84%)

Delayed Quote Updated: 2:14 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

64 65 Next >

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

July 30, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

July 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 30, 2026

From Law Offices of Howard G. Smith

Via Business Wire

2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore

July 30, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

Topics Energy

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

July 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Hims & Hers Responds to FTC Lawsuit

July 29, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HC...

Via StockStory

Why Is Hims & Hers Health Stock Surging on Thursday? ↗

July 23, 2026

Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.

Via Benzinga

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds

July 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 21, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 20.67% on an annualized basis producing an average annual return of 31.83%. Currently, Hims & Hers Health has a...

Via Benzinga

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

July 17, 2026

From Hims & Hers

Via Business Wire

3 Reasons HIMS Has Explosive Upside Potential

July 17, 2026

Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time,...

Via StockStory

Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data

July 15, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

July 13, 2026

From Hims & Hers

Via Business Wire

1 Stock Under $50 with Exciting Potential and 2 Facing Challenges

July 13, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

Via The Motley Fool

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗

July 06, 2026

Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.

Via MarketBeat

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 01, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an annualized basis producing an average annual return of 28.89%. Currently, Hims & Hers Health has a...

Via Benzinga

Hims & Hers Stock Surges as Analysts Lift Price Targets ↗

July 01, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Canaccord Genuity raised their respective price targets on the stock.

Via Benzinga

Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today ↗

June 23, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an annualized basis producing an average annual return of 25.67%. Currently, Hims & Hers Health has a...

Via Benzinga

June 23, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

1 Surging Stock Worth Your Attention and 2 We Find Risky

June 22, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

Topics Supply Chain

Hims & Hers Stock Jumps After Barclays Raises Price Target ↗

June 18, 2026

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target from $29 to $39.

Via Benzinga

Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know ↗

June 16, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher on Tuesday as the stock continues to rebound from recent profit-taking.

Via Benzinga

3 Market-Beating Stocks with Exciting Potential

June 16, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock ↗

June 05, 2026

This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic?

Via The Motley Fool

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

June 04, 2026

From Hims & Hers

Via Business Wire

1 Growth Stock Set to Flourishand 2 We Ignore

June 04, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Topics Economy

Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

June 02, 2026

From Hims & Hers

Via Business Wire

2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds

June 02, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.